| Dr Zachary Karl Parrett, PSYD | |
|
4101 S 4th St, Leavenworth, KS 66048-5014 | |
| (913) 682-2000 | |
| Not Available |
| Full Name | Dr Zachary Karl Parrett |
|---|---|
| Gender | Male |
| Speciality | Psychologist |
| Location | 4101 S 4th St, Leavenworth, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205275724 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | LP2125 (Kansas) | Primary |
| 103TC0700X | Psychologist - Clinical | LP2125 (Kansas) | Secondary |
| 103TH0004X | Psychologist - Health | LP2125 (Kansas) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zachary Karl Parrett, PSYD 323 Ne Landings Dr, Lees Summit, MO 64064-1586 Ph: (816) 877-1668 | Dr Zachary Karl Parrett, PSYD 4101 S 4th St, Leavenworth, KS 66048-5014 Ph: (913) 682-2000 |
News Archive
Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that its subsidiary, Biovail Laboratories International SRL (BLS), has entered into an agreement with Santhera Pharmaceuticals (Switzerland) Ltd., a subsidiary of Santhera Pharmaceuticals Holding AG (SIX: SANN) to acquire the U.S. and Canadian rights to develop and commercialize Santhera's JP-1730/fipamezole for the treatment of Dyskinesia in Parkinson's Disease (DPD). JP-1730/ fipamezole is a first-in-class compound that, in a recent Phase IIb study, displayed the potential to reduce levodopa-induced dyskinesia.
An antibody treatment reduces the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant chronic obstructive pulmonary disease (COPD), according to the results of two large international trials presented today at the European Respiratory Society International Congress in Milan, Italy, and simultaneously published in the New England Journal of Medicine.
Pulmonary embolism is a condition where a clot forms and blocks the arteries of the lungs and this restricts the blood flow to the lungs and lowers the amount of oxygen reaching the different organs. Statistics from the National Institutes of Health show that pulmonary embolism leads to nearly 200,000 to 300,000 deaths in the United States annually putting it at number three in cardiovascular diseases right after heart attack and stroke.
Days after Afghanistan vaccinated more than 7 million children against polio, the world's top health official and Afghan President Hamid Karzai pledged to capitalize swiftly on the country's remarkable progress towards eradicating the disease.
› Verified 2 days ago
Dr. Paula L. Timmons, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 Fax: 913-758-4273 | |
Dr. Kylie L Dowell, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 | |
Deborah Lynn Weidinger, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 3515 S 4th Street, Professional Association, Leavenworth, KS 66048 Phone: 913-651-8415 Fax: 913-772-8580 | |
Dr. Amber D. Guzman, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 Fax: 913-946-1561 | |
Jim Sharpnack, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 500 Limit St, Leavenworth, KS 66048 Phone: 913-682-5118 Fax: 913-682-4664 | |
Dakota Mcnamara Thornblade, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 500 Limit St, Leavenworth, KS 66048 Phone: 913-682-4664 | |
Dr. Erin Elisabeth Mills, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4101 S 4th St, Leavenworth, KS 66048 Phone: 913-682-2000 |